Johnson Pharmacare Ltd. - Research Center
532154 JOHNPHARMA Group (XT) BSE data
Results
Statement
More
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Mar ' 19 |
Equity share capital
55.00 |
55.00 |
50.00 |
50.00 |
50.00 |
Share application money
Preference share capital
Reserves & surplus
Secured loans
Unsecured loans
Total
58.85 |
58.85 |
58.83 |
58.77 |
59.91 |
Gross block
Less : revaluation reserve
Less : accumulated depreciation
Net block
Capital work-in-progress
Investments
45.56 |
54.18 |
52.26 |
52.26 |
53.13 |
Current assets, loans & advances
14.27 |
5.80 |
7.22 |
6.51 |
6.80 |
Less : current liabilities & provisions
Total net current assets
13.30 |
4.67 |
6.57 |
6.51 |
6.78 |
Miscellaneous expenses not written
Total
58.85 |
58.85 |
58.83 |
58.77 |
59.91 |
Book value of unquoted investments
45.56 |
54.18 |
41.80 |
41.80 |
53.13 |
Market value of quoted investments
Contingent liabilities
Number of equity sharesoutstanding (Lacs)
5500.00 |
5500.00 |
500.00 |
500.00 |
500.00 |